Another question that attendees at the AGM (or is it BGM, Biannual general Meeting) might want to ask is:
Who is paying for the current ring round of shareholders asking for them to entrust their proxy votes with management?
Is is Biophan themselves, in which case wouldn't they be better of spending that money on operational matters or paying off their debt? After all, we've established that they can buy shares on the open market and use them to pay off the "sewer rats", so the request for an increase in float to 800 million is strictly unnecessary, unless they actually want to disadvantage the private retail shareholder and feed the rats.
Or is it the "sewer rats" who are paying for this? If so, that's all you need to know about this company and for whose benefit it's being run.
In either case, it's interesting that they've had to resort to telemarketing to ensure they win the vote. Suggests it might be closer than one would imagine, even with all those shares in the hands of Mr. Lanzafame and his friends.
Don't be too surprised if the meeting gets cancelled at the very last moment.
Market Data 
Markets 
AI
